280 related articles for article (PubMed ID: 17021816)
1. PET imaging of apoptosis with (64)Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V.
Cauchon N; Langlois R; Rousseau JA; Tessier G; Cadorette J; Lecomte R; Hunting DJ; Pavan RA; Zeisler SK; van Lier JE
Eur J Nucl Med Mol Imaging; 2007 Feb; 34(2):247-58. PubMed ID: 17021816
[TBL] [Abstract][Full Text] [Related]
2. In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy.
Lewis MR; Wang M; Axworthy DB; Theodore LJ; Mallet RW; Fritzberg AR; Welch MJ; Anderson CJ
J Nucl Med; 2003 Aug; 44(8):1284-92. PubMed ID: 12902420
[TBL] [Abstract][Full Text] [Related]
3. Pretargeted radioimmunotherapy with a single-chain antibody/streptavidin construct and radiolabeled DOTA-biotin: strategies for reduction of the renal dose.
Förster GJ; Santos EB; Smith-Jones PM; Zanzonico P; Larson SM
J Nucl Med; 2006 Jan; 47(1):140-9. PubMed ID: 16391198
[TBL] [Abstract][Full Text] [Related]
4. Biological evaluation of avidin-based tumor pretargeting with DOTA-Triazole-Biotin constructed via versatile Cu(I) catalyzed click chemistry.
Uppal JK; Varshney R; Hazari PP; Chuttani K; Kaushik NK; Mishra AK
J Drug Target; 2011 Jul; 19(6):418-26. PubMed ID: 20678008
[TBL] [Abstract][Full Text] [Related]
5. Structural requirements for in vivo detection of cell death with 99mTc-annexin V.
Tait JF; Smith C; Blankenberg FG
J Nucl Med; 2005 May; 46(5):807-15. PubMed ID: 15872355
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic abscess imaging with 99mTc-HYNIC-rh-Annexin-V.
Penn DL; Kim C; Zhang K; Mukherjee A; Devakumar D; Jungkind D; Thakur ML
Nucl Med Biol; 2010 Jan; 37(1):29-34. PubMed ID: 20122665
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.
Valtorta S; Belloli S; Sanvito F; Masiello V; Di Grigoli G; Monterisi C; Fazio F; Picchio M; Moresco RM
J Nucl Med; 2013 Jul; 54(7):1106-12. PubMed ID: 23699667
[TBL] [Abstract][Full Text] [Related]
8. Time course of Paclitaxel-induced apoptosis in an experimental model of virus-induced breast cancer.
Erba PA; Manfredi C; Lazzeri E; Minichilli F; Pauwels EK; Sbrana A; Strauss HW; Mariani G
J Nucl Med; 2010 May; 51(5):775-81. PubMed ID: 20395330
[TBL] [Abstract][Full Text] [Related]
9. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.
Su FM; Beaumier P; Axworthy D; Atcher R; Fritzberg A
Nucl Med Biol; 2005 Oct; 32(7):741-7. PubMed ID: 16243650
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis.
Yagle KJ; Eary JF; Tait JF; Grierson JR; Link JM; Lewellen B; Gibson DF; Krohn KA
J Nucl Med; 2005 Apr; 46(4):658-66. PubMed ID: 15809489
[TBL] [Abstract][Full Text] [Related]
11. Three-step tumor imaging with biotinylated monoclonal antibody, streptavidin and 111In-DTPA-biotin.
Nakamoto Y; Saga T; Sakahara H; Yao Z; Zhang M; Sato N; Zhao S; Nakada H; Yamashina I; Konishi J
Nucl Med Biol; 1998 Feb; 25(2):95-9. PubMed ID: 9468022
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis.
Ohtsuki K; Akashi K; Aoka Y; Blankenberg FG; Kopiwoda S; Tait JF; Strauss HW
Eur J Nucl Med; 1999 Oct; 26(10):1251-8. PubMed ID: 10541822
[TBL] [Abstract][Full Text] [Related]
13. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
14. A simplified method for preparation of 99mTc-annexin V and its biologic evaluation for in vivo imaging of apoptosis after photodynamic therapy.
Subbarayan M; Häfeli UO; Feyes DK; Unnithan J; Emancipator SN; Mukhtar H
J Nucl Med; 2003 Apr; 44(4):650-6. PubMed ID: 12679412
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells.
Vangestel C; Peeters M; Oltenfreiter R; D'Asseler Y; Staelens S; Van Steenkiste M; Philippé J; Kusters D; Reutelingsperger C; Van Damme N; Van de Wiele C
Nucl Med Biol; 2010 Nov; 37(8):965-75. PubMed ID: 21055628
[TBL] [Abstract][Full Text] [Related]
16. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
Wu Y; Zhang X; Xiong Z; Cheng Z; Fisher DR; Liu S; Gambhir SS; Chen X
J Nucl Med; 2005 Oct; 46(10):1707-18. PubMed ID: 16204722
[TBL] [Abstract][Full Text] [Related]
17. 99mTc-labeled annexin V fragments: a potential SPECT radiopharmaceutical for imaging cell death.
Mukherjee A; Kothari K; Tóth G; Szemenyei E; Sarma HD; Környei J; Venkatesh M
Nucl Med Biol; 2006 Jul; 33(5):635-43. PubMed ID: 16843838
[TBL] [Abstract][Full Text] [Related]
18. Molecular imaging of cell death in tumors. Increasing annexin A5 size reduces contribution of phosphatidylserine-targeting function to tumor uptake.
Ungethüm L; Chatrou M; Kusters D; Schurgers L; Reutelingsperger CP
PLoS One; 2014; 9(5):e96749. PubMed ID: 24801051
[TBL] [Abstract][Full Text] [Related]
19. MBP-annexin V radiolabeled directly with iodine-124 can be used to image apoptosis in vivo using PET.
Dekker B; Keen H; Lyons S; Disley L; Hastings D; Reader A; Ottewell P; Watson A; Zweit J
Nucl Med Biol; 2005 Apr; 32(3):241-52. PubMed ID: 15820759
[TBL] [Abstract][Full Text] [Related]
20. Pretargeted radioimmunotherapy of mesothelin-expressing cancer using a tetravalent single-chain Fv-streptavidin fusion protein.
Sato N; Hassan R; Axworthy DB; Wong KJ; Yu S; Theodore LJ; Lin Y; Park L; Brechbiel MW; Pastan I; Paik CH; Carrasquillo JA
J Nucl Med; 2005 Jul; 46(7):1201-9. PubMed ID: 16000290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]